Matthew J. D'Onofrio Net Worth

The estimated Net Worth of Matthew J D'onofrio is at least $1.91 Milion dollars as of 10 December 2020. Mr onofrio owns over 46,000 units of Evoke Pharma Inc stock worth over $1,141,696 and over the last 11 years he sold EVOK stock worth over $133,860. In addition, he makes $634,638 as Co-Founder, Chief Bus. Officer, Exec. VP oraz Treasurer & Sec. at Evoke Pharma Inc.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Mr Onofrio EVOK stock SEC Form 4 insiders trading

Mr has made over 2 trades of the Evoke Pharma Inc stock since 2020, according to the Form 4 filled with the SEC. Most recently he sold 46,000 units of EVOK stock worth $133,860 on 10 December 2020.

The largest trade he's ever made was selling 46,000 units of Evoke Pharma Inc stock on 10 December 2020 worth over $133,860. On average, Mr trades about 3,833 units every 0 days since 2013. As of 10 December 2020 he still owns at least 283,997 units of Evoke Pharma Inc stock.

You can see the complete history of Mr onofrio stock trades at the bottom of the page.

Mr. Matthew J. D'Onofrio biography

Matthew J. D'Onofrio is the Co-Founder, Chief Bus. Officer, Exec. VP, Treasurer & Sec. at Evoke Pharma Inc.

What is the salary of Mr Onofrio?

As the Co-Founder, Chief Bus. Officer, Exec. VP oraz Treasurer & Sec. of Evoke Pharma Inc, the total compensation of Mr Onofrio at Evoke Pharma Inc is $634,638. There are 1 executives at Evoke Pharma Inc getting paid more, with David A. Gonyer having the highest compensation of $857,325.

How old is Mr Onofrio?

Mr Onofrio is 51, he's been the Co-Founder, Chief Bus. Officer, Exec. VP oraz Treasurer & Sec. of Evoke Pharma Inc since . There are 7 older and 2 younger executives at Evoke Pharma Inc. The oldest executive at Evoke Pharma Inc is Dr. Marilyn R. Carlson, 73, who is the Chief Medical Officer.

What's Mr Onofrio's mailing address?

Matthew's mailing address filed with the SEC is C/O EVOKE PHARMA, INC., 420 STEVENS AVENUE, SUITE 230, SOLANA BEACH, CA, 92075.

Insiders trading at Evoke Pharma Inc

Over the last 11 years, insiders at Evoke Pharma Inc have traded over $3,263,070 worth of Evoke Pharma Inc stock and bought 954,000 units worth $2,502,800 . The most active insiders traders include Nicole Vitullo, Jesse I Treu oraz Brian K Halak. On average, Evoke Pharma Inc executives and independent directors trade stock every 100 days with the average trade being worth of $308,145. The most recent stock trade was executed by David A Gonyer on 11 December 2020, trading 72,000 units of EVOK stock currently worth $209,520.

What does Evoke Pharma Inc do?

evoke pharma is a biotechnology company located in 505 lomas santa fe dr, solana beach, california, united states.

Complete history of Mr onofrio stock trades at Evoke Pharma Inc

Evoke Pharma Inc executives and stock owners

Evoke Pharma Inc executives and other stock owners filed with the SEC include:

• David A. Gonyer,
  Co-Founder, CEO, Pres & Director
• Matthew J. D'Onofrio,
  Co-Founder, Chief Bus. Officer, Exec. VP, Treasurer & Sec.
• Dr. Marilyn R. Carlson,
  Chief Medical Officer
• David Gonyer,
  CEO, Founder, Director
• Matthew D'Onofrio,
  Executive Vice President, Chief Business Officer Treasurer, Secretary ,
• Marilyn Carlson,
  Chief Medical Officer
• Ken Widder,
  Director
• Ann Rhoads,
  Director
• Todd Brady,
  Director
• Cam Garner,
  Chairman and Co Founder
• Christopher Quesenberry,
  Chief Commercial Officer - Gimoti (TM)
• Scott L Glenn,
  Director
• Parters Vii L Pblair James ...,
  
• Vii Associates Lpblair Jame...,
  
• Gp Iii, Llclatterell Patric...,
  
• Vickie S Reed,
  
• Vii Associates Lp Dp,
  10% owner
• Gp Iii, Llclatterell Patric...,
  
• Brian H Dovey,
  10% owner
• James C Blair,
  10% owner
• Jesse I Treu,
  10% owner
• Brian K Halak,
  10% owner
• Nicole Vitullo,
  10% owner
• Kathleen K Schoemaker,
  10% owner
• Parters Vii L P Domain,
  10% owner
• Malcolm R Hill,
  
• Vii Associates Lpblair Jame...,
  
• Parters Vii L Pblair James ...,
  
• Mark Kowieski,
  Chief Financial Officer